Clinical course of hyperprolactinemia in children and adolescents: A review of 21 cases
dc.contributor.buuauthor | Eren, Erdal | |
dc.contributor.buuauthor | Yapıcı, Senay | |
dc.contributor.buuauthor | Çakır, Esra Deniz Papatya | |
dc.contributor.buuauthor | Ceylan, Latife Aytekin | |
dc.contributor.buuauthor | Saǧlam, Halil | |
dc.contributor.buuauthor | Tarım, Ömer Faruk | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik Endokrinoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı | tr_TR |
dc.contributor.orcid | 0000-0003-0710-5422 | tr_TR |
dc.contributor.orcid | 0000-0002-1684-1053 | tr_TR |
dc.contributor.researcherid | C-7392-2019 | tr_TR |
dc.contributor.researcherid | AAH-1155-2021 | tr_TR |
dc.contributor.researcherid | AAM-1734-2020 | tr_TR |
dc.contributor.scopusid | 36113153400 | tr_TR |
dc.contributor.scopusid | 44161566600 | tr_TR |
dc.contributor.scopusid | 37003613900 | tr_TR |
dc.contributor.scopusid | 40461059700 | tr_TR |
dc.contributor.scopusid | 35612700100 | tr_TR |
dc.contributor.scopusid | 6701427186 | tr_TR |
dc.date.accessioned | 2021-12-13T13:34:16Z | |
dc.date.available | 2021-12-13T13:34:16Z | |
dc.date.issued | 2011-06 | |
dc.description.abstract | Objective: Hyperprolactinemia may be due to various etiological factors and may present with different signs and symptoms. It is relatively less frequent in childhood than in adulthood. The aim of this study was to evaluate retrospectively the clinical course and outcome of hyperprolactinemia in pediatric patients. Methods: We investigated the records of 21 patients with hyperprolactinemia who attended a tertiary hospital. Results: Menstrual problems, galactorrhea, and headache were the most common presenting symptoms. Hyperprolactinemia was due to microadenoma in 10, macroadenoma in 7, and was drug-induced in 4 patients. Bromocriptine and cabergoline were equally effective in lowering serum prolactin levels. Surgical treatment in children with macroprolactinoma was not curative and dopamine agonist therapy was required postoperatively. Conclusion: In the presence of any clinical symptom or sign suggestive of suppression of the pituitary-gonadal axis, hyperprolactinemia should not be forgotten as a probable diagnosis. Medical therapy seems effective in microadenoma. Surgical therapy may not be successful in macroadenoma and recurrence is frequent. | en_US |
dc.identifier.citation | Eren, E. vd. (2011). "Clinical course of hyperprolactinemia in children and adolescents: A review of 21 cases". Journal of Clinical Research in Pediatric Endocrinology, 3(2), 65-69. | en_US |
dc.identifier.endpage | 69 | tr_TR |
dc.identifier.issn | 1308-5727 | |
dc.identifier.issn | 1308-5735 | |
dc.identifier.issue | 2 | tr_TR |
dc.identifier.pubmed | 21750634 | tr_TR |
dc.identifier.scopus | 2-s2.0-79959224580 | tr_TR |
dc.identifier.startpage | 65 | tr_TR |
dc.identifier.uri | https://doi.org/10.4274/jcrpe.v3i2.14 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119443/ | |
dc.identifier.uri | http://hdl.handle.net/11452/23218 | |
dc.identifier.volume | 3 | tr_TR |
dc.identifier.wos | 000497376200005 | tr_TR |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | BKCIS | en_US |
dc.language.iso | en | en_US |
dc.publisher | Galenos Yayıncılık | tr_TR |
dc.relation.journal | Journal of Clinical Research in Pediatric Endocrinology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Endocrinology & metabolism | en_US |
dc.subject | Pediatrics | en_US |
dc.subject | Prolactin | en_US |
dc.subject | Puberty | en_US |
dc.subject | Prolactinoma | en_US |
dc.subject | Pituitary | en_US |
dc.subject.emtree | Bromocriptine | en_US |
dc.subject.emtree | Bromocriptine mesilate | en_US |
dc.subject.emtree | Cabergoline | en_US |
dc.subject.emtree | Dopamine receptor stimulating agent | en_US |
dc.subject.emtree | Prolactin | en_US |
dc.subject.emtree | Adolescent | en_US |
dc.subject.emtree | Child | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Disease course | en_US |
dc.subject.emtree | Drug efficacy | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Galactorrhea | en_US |
dc.subject.emtree | Headache | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hyperprolactinemia | en_US |
dc.subject.emtree | Hypophysis gonad system | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Menstruation disorder | en_US |
dc.subject.emtree | Microadenoma | en_US |
dc.subject.emtree | Postoperative period | en_US |
dc.subject.emtree | Prolactinoma | en_US |
dc.subject.emtree | Recurrence risk | en_US |
dc.subject.emtree | Retrospective study | en_US |
dc.subject.emtree | Review | en_US |
dc.subject.emtree | Symptom | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Dopamine agonists | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hyperprolactinemia | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Pituitary neoplasms | en_US |
dc.subject.mesh | Prolactin | en_US |
dc.subject.mesh | Prolactinoma | en_US |
dc.subject.mesh | Retrospective studies | en_US |
dc.subject.mesh | Turkey | en_US |
dc.subject.scopus | Prolactinoma; Cabergoline; Dopamine Receptor Stimulating Agent | en_US |
dc.subject.wos | Endocrinology & metabolism | en_US |
dc.subject.wos | Pediatrics | en_US |
dc.title | Clinical course of hyperprolactinemia in children and adolescents: A review of 21 cases | en_US |
dc.type | Review | |
dc.type | Book Chapter |
Files
Original bundle
1 - 1 of 1